(KV)
Live / Allowed — Fourth extension granted (statement of use) (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 Dec 2021 filing date already counts against anyone who files later.
Record
- Serial number
- 97150686
- Mark type
- Design + words
- Filed
- 01 Dec 2021
- Published for opposition
- 16 Jan 2024
- Attorney of record
- DRAEKE H WESEMAN
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for use in immunotherapy, namely, oncolytic vaccinia viruses; Pharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith; Biopharmaceutical preparations for the treatment of cancer; Biopharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith
Owner
- KALIVIR IMMUNOTHERAPEUTICS, INC., Pittsburgh, PA, US
- KALIVIR IMMUNOTHERAPEUTICS, INC., Pittsburgh, PA, US
Board proceedings on this mark
- Ex Parte Appeal No. 97150686 — KALIVIR IMMUNOTHERAPEUTICS, INC., filed 25 Oct 2023 (Terminated)
Prosecution history
- 14 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Mar 2026 — SOU EXTENSION 4 GRANTED
- 09 Mar 2026 — SOU EXTENSION 4 FILED
- 09 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — SOU EXTENSION 3 GRANTED
- 10 Sept 2025 — SOU EXTENSION 3 FILED
- 10 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2025 — SOU EXTENSION 2 GRANTED
- 12 Mar 2025 — SOU EXTENSION 2 FILED
- 12 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2024 — SOU EXTENSION 1 GRANTED